{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:21:05Z","timestamp":1788448865878,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-02138"],"award-info":[{"award-number":["2017-02138"]}],"id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12020-018-1734-x","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:35:07Z","timestamp":1537072507000},"page":"566-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Kjellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Calissendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"issue":"9486","key":"1734_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"J.W. Lenders, G. Eisenhofer, M. Mannelli, K. Pacak, Phaeochromocytoma. Lancet 366(9486), 665\u2013675 (2005). \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)67139-5","journal-title":"Lancet"},{"issue":"1","key":"1734_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","volume":"7","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, M. Kjellman, J. Calissendorff, Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr. Connect. 7(1), 186\u2013192 (2018). \n                    https:\/\/doi.org\/10.1530\/EC-17-0321","journal-title":"Endocr. Connect."},{"key":"1734_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0001-x","volume":"15","author":"H Yeomans","year":"2015","unstructured":"H. Yeomans, J. Calissendorff, C. Volpe, H. Falhammar, B. Mannheimer, Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study. BMC Endocr. Disord. 15, 6 (2015). \n                    https:\/\/doi.org\/10.1186\/s12902-015-0001-x","journal-title":"BMC Endocr. Disord."},{"issue":"8","key":"1734_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4158\/EP15618.OR","volume":"21","author":"J Patrova","year":"2015","unstructured":"J. Patrova, I. Jarocka, H. Wahrenberg, H. Falhammar, Clinical outcomes in adrenal incidentaloma: experience from one center. Endocr. Pract. 21(8), 870\u2013877 (2015). \n                    https:\/\/doi.org\/10.4158\/EP15618.OR","journal-title":"Endocr. Pract."},{"issue":"2","key":"1734_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85(2), 637\u2013644 (2000). \n                    https:\/\/doi.org\/10.1210\/jcem.85.2.6372","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1734_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young Jr., S. Endocrine, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915\u20131942 (2014). \n                    https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1734_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1530\/EJE-15-0483","volume":"173","author":"A Riester","year":"2015","unstructured":"A. Riester, D. Weismann, M. Quinkler, U.D. Lichtenauer, S. Sommerey, R. Halbritter, R. Penning, C. Spitzweg, J. Schopohl, F. Beuschlein, M. Reincke, Life-threatening events in patients with pheochromocytoma. Eur. J. Endocrinol. 173(6), 757\u2013764 (2015). \n                    https:\/\/doi.org\/10.1530\/EJE-15-0483","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"1734_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4158\/EP171914.RA","volume":"23","author":"B Mesmar","year":"2017","unstructured":"B. Mesmar, S. Poola-Kella, R. Malek, The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature. Endocr. Pract. 23(8), 999\u20131005 (2017). \n                    https:\/\/doi.org\/10.4158\/EP171914.RA","journal-title":"Endocr. Pract."},{"issue":"5","key":"1734_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/01.HYP.29.5.1133","volume":"29","author":"PF Plouin","year":"1997","unstructured":"P.F. Plouin, G. Chatellier, I. Fofol, P. Corvol, Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29(5), 1133\u20131139 (1997)","journal-title":"Hypertension"},{"issue":"2","key":"1734_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/cen.12536","volume":"82","author":"D Weismann","year":"2015","unstructured":"D. Weismann, D. Liu, T. Bergen, M. Peitzsch, A. Raida, M. Wagner, M. Fassnacht, F. Weidemann, B. Allolio, Hypertension and hypertensive cardiomyopathy in patients with a relapse-free history of phaeochromocytoma. Clin. Endocrinol. 82(2), 188\u2013196 (2015). \n                    https:\/\/doi.org\/10.1111\/cen.12536","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"1734_CR11","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/jc.2003-030000","volume":"88","author":"TD Wiesner","year":"2003","unstructured":"T.D. Wiesner, M. Bluher, M. Windgassen, R. Paschke, Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J. Clin. Endocrinol. Metab. 88(8), 3632\u20133636 (2003). \n                    https:\/\/doi.org\/10.1210\/jc.2003-030000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1734_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","volume":"23","author":"G Eisenhofer","year":"2012","unstructured":"G. Eisenhofer, A.S. Tischler, R.R. de Krijger, Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr. Pathol. 23(1), 4\u201314 (2012). \n                    https:\/\/doi.org\/10.1007\/s12022-011-9188-1","journal-title":"Endocr. Pathol."},{"issue":"2","key":"1734_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"Jekaterina Patrova","year":"2017","unstructured":"J. Patrova, M. Kjellman, H. Wahrenberg, H. Falhammar, Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-017-1400-8","journal-title":"Endocrine"},{"issue":"9","key":"1734_CR14","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100(9), 3520\u20133528 (2015). \n                    https:\/\/doi.org\/10.1210\/JC.2015-2093","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1734_CR15","first-page":"69","volume":"38","author":"G Eisenhofer","year":"2017","unstructured":"G. Eisenhofer, B. Klink, S. Richter, J.W. Lenders, M. Robledo, Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing. Clin. Biochem. Rev. 38(2), 69\u2013100 (2017)","journal-title":"Clin. Biochem. Rev."},{"issue":"1","key":"1734_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12020-016-1127-y","volume":"55","author":"H Falhammar","year":"2017","unstructured":"H. Falhammar, J. Calissendorff, C. Hoybye, Frequency of Cushing\u2019s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center. Endocrine 55(1), 296\u2013302 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1127-y","journal-title":"Endocrine"},{"key":"1734_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-016-0095-9","volume":"16","author":"J Calissendorff","year":"2016","unstructured":"J. Calissendorff, F. Calissendorff, H. Falhammar, Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades. BMC Endocr. Disord. 16, 15 (2016). \n                    https:\/\/doi.org\/10.1186\/s12902-016-0095-9","journal-title":"BMC Endocr. Disord."},{"issue":"3","key":"1734_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MED.0000000000000330","volume":"24","author":"A Roman-Gonzalez","year":"2017","unstructured":"A. Roman-Gonzalez, C. Jimenez, Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. Curr. Opin. Endocrinol. Diabetes Obes. 24(3), 174\u2013183 (2017). \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000330","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"1734_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00464-012-2451-9","volume":"27","author":"TA Goers","year":"2013","unstructured":"T.A. Goers, M. Abdo, J.F. Moley, B.D. Matthews, M. Quasebarth, L.M. Brunt, Outcomes of resection of extra-adrenal pheochromocytomas\/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma. Surg. Endosc. 27(2), 428\u2013433 (2013). \n                    https:\/\/doi.org\/10.1007\/s00464-012-2451-9","journal-title":"Surg. Endosc."},{"issue":"4","key":"1734_CR20","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1210\/jc.2004-1398","volume":"90","author":"L Amar","year":"2005","unstructured":"L. Amar, A. Servais, A.P. Gimenez-Roqueplo, F. Zinzindohoue, G. Chatellier, P.F. Plouin, Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J. Clin. Endocrinol. Metab. 90(4), 2110\u20132116 (2005). \n                    https:\/\/doi.org\/10.1210\/jc.2004-1398","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"1734_CR21","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2017-00357","volume":"102","author":"H Komada","year":"2017","unstructured":"H. Komada, Y. Hirota, A. So, T. Nakamura, Y. Okuno, H. Fukuoka, G. Iguchi, Y. Takahashi, K. Sakaguchi, W. Ogawa, Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma. J. Clin. Endocrinol. Metab. 102(9), 3400\u20133405 (2017). \n                    https:\/\/doi.org\/10.1210\/jc.2017-00357","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1734_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","volume":"143","author":"VE Strong","year":"2008","unstructured":"V.E. Strong, T. Kennedy, H. Al-Ahmadie, L. Tang, J. Coleman, Y. Fong, M. Brennan, R.A. Ghossein, Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis. Surgery 143(6), 759\u2013768 (2008). \n                    https:\/\/doi.org\/10.1016\/j.surg.2008.02.007","journal-title":"Surgery"},{"issue":"5","key":"1734_CR23","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"P.F. Plouin, L. Amar, O.M. Dekkers, M. Fassnacht, A.P. Gimenez-Roqueplo, J.W. Lenders, C. Lussey-Lepoutre, O. Steichen; Guideline Working, G., European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur. J. Endocrinol. \/ Eur. Fed. Endocr. Soc. 174(5), G1\u2013G10 (2016). \n                    https:\/\/doi.org\/10.1530\/EJE-16-0033","journal-title":"Eur. J. Endocrinol. \/ Eur. Fed. Endocr. Soc."},{"issue":"4","key":"1734_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1677\/ERC-08-0049","volume":"15","author":"HJ Timmers","year":"2008","unstructured":"H.J. Timmers, F.M. Brouwers, A.R. Hermus, F.C. Sweep, A.A. Verhofstad, A.L. Verbeek, K. Pacak, J.W. Lenders, Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. Endocr. Relat. Cancer 15(4), 1127\u20131133 (2008). \n                    https:\/\/doi.org\/10.1677\/ERC-08-0049","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"1734_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125426","volume":"10","author":"E Grouzmann","year":"2015","unstructured":"E. Grouzmann, O. Tschopp, F. Triponez, M. Matter, S. Bilz, M. Brandle, T. Drechser, S. Sigrist, H. Zulewski, C. Henzen, S. Fischli, K. Abid, , Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?. PLoS One 10(5), e0125426 2015). Doi:\n                    https:\/\/doi.org\/10.1371\/journal.pone.0125426","journal-title":"PLoS One"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1734-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T02:44:38Z","timestamp":1569206678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1734-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1734-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Regional Ethical Review Board in Stockholm, Sweden, approved the study and since this was a retrospective study formal consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}